Cargando…
Radiotherapy in combination with systemic therapies for brain metastases: current status and progress
Brain metastases (BMs) are the most common cause of intracranial neoplasms in adults with poor prognosis. Most BMs originate from lung cancer, breast cancer, or melanoma. Radiotherapy (RT), including whole brain radiotherapy (WBRT) and stereotactic radiation surgery (SRS), has been widely explored a...
Autores principales: | Liu, Lei, Chen, Wanqi, Zhang, Ruopeng, Wang, Yuekun, Liu, Penghao, Lian, Xin, Zhang, Fuquan, Wang, Yu, Ma, Wenbin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Compuscript
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7721093/ https://www.ncbi.nlm.nih.gov/pubmed/33299643 http://dx.doi.org/10.20892/j.issn.2095-3941.2020.0109 |
Ejemplares similares
-
Imposing Phase II and Phase III Clinical Trials of Targeted Drugs for Glioblastoma: Current Status and Progress
por: Wang, Yaning, et al.
Publicado: (2021) -
The current status and future of radiotherapy for spinal bone metastases
por: Ejima, Yasuo, et al.
Publicado: (2015) -
Optimal Therapies for Recurrent Glioblastoma: A Bayesian Network Meta-Analysis
por: Chen, Wenlin, et al.
Publicado: (2021) -
Retrospective study of hypofractionated stereotactic radiotherapy combined with whole brain radiotherapy for patients with brain metastases
por: Xie, Xue-Yi, et al.
Publicado: (2022) -
Current advances in the selection of adjuvant radiotherapy regimens for keloid
por: Wang, Weihao, et al.
Publicado: (2022)